Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
PHIO
$1.13
+0.89%
PHIO
· Phio Pharmaceuticals Corp.
$1.13
+0.01 (+0.89%)
At close · Aug 28
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“The Company has limited cash resources, has incurred recurring operating losses and negative cash flows from its operations since its inception and has not yet recognized any product revenues. These factors have previously raised doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$13.13M
Shares
11.62M
All earnings calls
Earnings call · FY2025 Q4
Phio Pharmaceuticals Corp. (PHIO) Q4 2025 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Net income · derived Q4
-$2.37M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 5, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 5, 2026 · complete as-filed document